165 related articles for article (PubMed ID: 19133252)
1. RAGE polymorphisms, renal function and histological finding at 12 months after renal transplantation.
Kalousová M; Brabcová I; Germanová A; Jáchymová M; Matl I; Mestek O; Bandúr S; Zima T; Viklický O
Clin Biochem; 2009 Mar; 42(4-5):347-52. PubMed ID: 19133252
[TBL] [Abstract][Full Text] [Related]
2. Genetic predisposition to advanced glycation end products toxicity is related to prognosis of chronic hemodialysis patients.
Kalousová M; Jáchymová M; Germanová A; Kubena AA; Tesar V; Zima T
Kidney Blood Press Res; 2010; 33(1):30-6. PubMed ID: 20185929
[TBL] [Abstract][Full Text] [Related]
3. Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer.
Krechler T; Jáchymová M; Mestek O; Zák A; Zima T; Kalousová M
Clin Biochem; 2010 Jul; 43(10-11):882-6. PubMed ID: 20398646
[TBL] [Abstract][Full Text] [Related]
4. The -429 T/C and -374 T/A gene polymorphisms of the receptor of advanced glycation end products gene (RAGE) are not risk factors for coronary artery disease in Slovene population with type 2 diabetes.
Kirbis J; Milutinović A; Steblovnik K; Teran N; Terzić R; Zorc M
Coll Antropol; 2004 Dec; 28(2):611-6. PubMed ID: 15666591
[TBL] [Abstract][Full Text] [Related]
5. Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients.
Kalousová M; Jáchymová M; Mestek O; Hodková M; Kazderová M; Tesar V; Zima T
Nephrol Dial Transplant; 2007 Jul; 22(7):2020-6. PubMed ID: 17347281
[TBL] [Abstract][Full Text] [Related]
6. Gene polymorphisms (G82S, 1704G/T, 2184A/G and 2245G/A) of the receptor of advanced glycation end products (RAGE) in plaque psoriasis.
Vasků V; Kanková K; Vasků A; Muzík J; Izakovicová Hollá L; Semrádová V; Vácha J
Arch Dermatol Res; 2002 May; 294(3):127-30. PubMed ID: 12029499
[TBL] [Abstract][Full Text] [Related]
7. Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with chronic allograft nephropathy and graft survival in Korean renal transplant recipients.
Cho JH; Huh S; Kwon TG; Choi JY; Hur IK; Lee EY; Park SH; Kim YL; Kim CD
Transplant Proc; 2008 Sep; 40(7):2355-60. PubMed ID: 18790234
[TBL] [Abstract][Full Text] [Related]
8. The functional -374T/A polymorphism of the receptor for advanced glycation end products may modulate Crohn's disease.
Däbritz J; Friedrichs F; Weinhage T; Hampe J; Kucharzik T; Lügering A; Broeckel U; Schreiber S; Spieker T; Stoll M; Foell D
Am J Physiol Gastrointest Liver Physiol; 2011 May; 300(5):G823-32. PubMed ID: 21311028
[TBL] [Abstract][Full Text] [Related]
9. Receptor for advanced glycation end products (RAGE)--soluble form (sRAGE) and gene polymorphisms in patients with breast cancer.
Tesarová P; Kalousová M; Jáchymová M; Mestek O; Petruzelka L; Zima T
Cancer Invest; 2007 Dec; 25(8):720-5. PubMed ID: 18058469
[TBL] [Abstract][Full Text] [Related]
10. Association of cytokine polymorphisms with subclinical progressive chronic allograft nephropathy in Japanese renal transplant recipients: preliminary study.
Satoh S; Saito M; Inoue K; Miura M; Komatsuda A; Habuchi T
Int J Urol; 2007 Nov; 14(11):990-4. PubMed ID: 17956522
[TBL] [Abstract][Full Text] [Related]
11. Impact of chemokine receptor CCR2 and CCR5 gene polymorphism on allograft outcome in North Indian renal transplant recipients.
Singh R; Kapoor R; Srivastava A; Mittal RD
Scand J Immunol; 2009 Jan; 69(1):51-6. PubMed ID: 19037908
[TBL] [Abstract][Full Text] [Related]
12. RAGE gene polymorphisms are associated with circulating levels of endogenous secretory RAGE but not with coronary artery disease in Chinese patients with type 2 diabetes mellitus.
Peng WH; Lu L; Wang LJ; Yan XX; Chen QJ; Zhang Q; Zhang RY; Shen WF
Arch Med Res; 2009 Jul; 40(5):393-8. PubMed ID: 19766904
[TBL] [Abstract][Full Text] [Related]
13. Association of RAGE gene polymorphisms with type 2 diabetes mellitus, diabetic retinopathy and diabetic nephropathy.
Kang P; Tian C; Jia C
Gene; 2012 May; 500(1):1-9. PubMed ID: 22475522
[TBL] [Abstract][Full Text] [Related]
14. Genetic variability of major inflammatory mediators has no impact on the outcome of kidney transplantation.
Brabcova I; Petrasek J; Hribova P; Hyklova K; Bartosova K; Lacha J; Viklický O
Transplantation; 2007 Oct; 84(8):1037-44. PubMed ID: 17989610
[TBL] [Abstract][Full Text] [Related]
15. Association of biochemical parameters and RAGE gene polymorphisms in healthy infants and their mothers.
Boor P; Celec P; Klenovicsová K; Vlková B; Szemes T; Minárik G; Turna J; Sebeková K
Clin Chim Acta; 2010 Aug; 411(15-16):1034-40. PubMed ID: 20359471
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 8 -251T>A and Interferon gamma +874A>T polymorphism: potential predictors of allograft outcome in renal transplant recipients from north India.
Singh R; Kesarwani P; Ahirwar DK; Kapoor R; Mittal RD
Transpl Immunol; 2009 May; 21(1):13-7. PubMed ID: 19189859
[TBL] [Abstract][Full Text] [Related]
17. No effect of C-reactive protein (CRP) haplotypes on CRP levels and post-transplant morbidity and mortality in renal transplantation.
Krüger B; Böger CA; Schröppel B; Farkas S; Schnitzbauer AA; Hoffmann U; Obed A; Murphy BT; Banas B; Krämer BK
Transpl Int; 2008 May; 21(5):452-8. PubMed ID: 18266777
[TBL] [Abstract][Full Text] [Related]
18. Impact of NOD2/CARD15 haplotypes on the outcome after kidney transplantation.
Krüger B; Böger CA; Schröppel B; Obed A; Hoffmann U; Murphy BT; Fischereder M; Holler E; Banas B; Krämer BK
Transpl Int; 2007 Jul; 20(7):600-7. PubMed ID: 17498224
[TBL] [Abstract][Full Text] [Related]
19. Receptor for advanced glycation end product polymorphisms and type 2 diabetes: the CODAM study.
Gaens KH; van Der Kallen CJ; van Greevenbroek MM; Feskens EJ; Stehouwer CD; Schalkwijk CG
Ann N Y Acad Sci; 2008 Apr; 1126():162-5. PubMed ID: 18079485
[TBL] [Abstract][Full Text] [Related]
20. Associations of receptor for advanced glycation end products -374 T/A and Gly82 Ser and peroxisome proliferator-activated receptor gamma Pro12Ala polymorphisms in Turkish coronary artery disease patients.
Aydoğan HY; Küçükhüseyin O; Tekeli A; Isbir T
Genet Test Mol Biomarkers; 2012 Feb; 16(2):134-7. PubMed ID: 21861709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
